2BB score and signals
Indaptus Therapeutics, Inc.’s current 2BB score is 23 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 14 | Very Weak |
| Quality | 20 | Weak |
| Risk | 21 | Low |
2BBBullish & Bearish
Indaptus Therapeutics, Inc. (INDP) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 23 out of 100.
Indaptus Therapeutics, Inc.’s current 2BB score is 23 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 14 | Very Weak |
| Quality | 20 | Weak |
| Risk | 21 | Low |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-10 | — | -1.4892 | — | $0.00 |
| 2026-08-11 | — | -1.6014 | — | $0.00 |
| 2026-05-12 | — | -1.9074 | — | $0.00 |
| 2026-03-10 | — | -4.4472 | — | $0.00 |